Literature DB >> 7353525

Release of dopamine from tuberoinfundibular neurons into pituitary stalk blood after prolactin or haloperidol administration.

G A Gudelsky, J C Porter.   

Abstract

The effects of PRL or haloperidol on the release of dopamine from tuberoinfundibular neurons were assessed by measuring the concentrations of dopamine in hypophysial portal plasma. The mean concentration of dopamine in portal plasma of male rats which had received an intracerebroventricular injection of PRL or a sc injection of haloperidol on the day before the collection of pituitary stalk blood was approximately 5 times that in stalk plasma of vehicle-treated control rats. The haloperidol-induced increase in the concentration of dopamine in pituitary stalk plasma appeared to be PRL mediated, since this effect of haloperidol was significantly attenuated in rats which had been pretreated with antiserum to PRL. These observations are consistent with the view that the mechanisms involved in the release of dopamine from tuberoinfundibular neurons are regulated, in part, by PRL. Moreover, in view of the inhibitory effect of dopamine on PRL-secretion, a PRL-induced increase in the release of dopamine from tuberoinfundibular neurons into hypophysial portal blood may be one mechanism by which PRL regulates its own secretion.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7353525     DOI: 10.1210/endo-106-2-526

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

1.  Morphometrical variations of prolactin cells in response to prolonged and systemic administration of Met-enkephalin in female rats.

Authors:  J Carretero; E Blanco; F Sánchez; J M Riesco; M Rubio; J A Juanes; R Vázquez
Journal:  Anat Embryol (Berl)       Date:  1992

2.  Differential sensitivity of specific neuronal populations of the rat hypothalamus to prolactin action.

Authors:  Tony J Sapsford; Ilona C Kokay; Lovisa Ostberg; Robert S Bridges; David R Grattan
Journal:  J Comp Neurol       Date:  2012-04-01       Impact factor: 3.215

Review 3.  The interaction between mediobasohypothalamic dopaminergic and endorphinergic neuronal systems as a key regulator of reproduction: an hypothesis.

Authors:  D D Rasmussen
Journal:  J Endocrinol Invest       Date:  1991-04       Impact factor: 4.256

Review 4.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

5.  Calmodulin and a cyclic nucleotide-dependent protein kinase facilitate the prolactin-induced increase in tyrosine hydroxylase activity in tuberoinfundibular dopaminergic neurons.

Authors:  L A Arbogast
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

Review 6.  Dopamine: Functions, Signaling, and Association with Neurological Diseases.

Authors:  Marianne O Klein; Daniella S Battagello; Ariel R Cardoso; David N Hauser; Jackson C Bittencourt; Ricardo G Correa
Journal:  Cell Mol Neurobiol       Date:  2018-11-16       Impact factor: 5.046

7.  The management of prolactin-secreting pituitary tumors.

Authors:  S R George; G N Burrow
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

8.  Central clock regulates the cervically stimulated prolactin surges by modulation of dopamine and vasoactive intestinal polypeptide release in ovariectomized rats.

Authors:  Maristela O Poletini; Jessica E Kennett; De'nise T McKee; Marc E Freeman
Journal:  Neuroendocrinology       Date:  2009-10-29       Impact factor: 4.914

9.  Regional differences in the effect of pargyline on dopamine concentrations in the rat hypophysis.

Authors:  M Holzbauer; K Racké; S P Mann; T Cooper; G Cohen; U Krause; D F Sharman
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

10.  Effect of human prolactin administration on gonadotropin and thyrotropin secretion in normal men.

Authors:  M E Molitch; R W Rebar; C P Barsano
Journal:  J Endocrinol Invest       Date:  1993-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.